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Definition 
Ion channels are used as biosensors in order to visualize the spatiotemporal changes that occur in 
cyclic nucleotides in living cells. 
 
1- Introduction 
Ion channels are pore-forming proteins that allow the flow of ions down their 
electrochemical gradient thus helping to establish and control the small voltage gradient across 
the plasma membrane of cells. They are present in the membranes that surround all biological 
cells and can be distinguished based upon their ion selectivity, gating mechanism, and sequence 
similarity. Ion channels can be voltage-gated, ligand-gated, pH-gated, or mechanically gated. 
These gating criteria along with a combination of sequence similarity and ion selectivity further 
subdivide ion channels into several subtypes:  
- Voltage-gated ion channels which open and close in response to membrane potential 
such as the voltage-gated sodium channels, voltage-gated calcium channels, and some 
transient receptor potential channels, normally referred to simply as TRP channels.  
- Ligand-gated ion channels, also known as ionotropic receptors, open in response to 
specific ligand molecules binding to the extracellular domain of the receptor protein. 
Examples of such channels include the cation-permeable "nicotinic" Acetylcholine 
receptor, ionotropic glutamate-gated receptors and ATP-gated P2X receptors, and the 
anion-permeable γ-aminobutyric acid-gated GABAA receptor. 
- Other gating includes the light-gated, the temperature-gated, mechanosensitive ion 
channels and the cyclic nucleotide-gated channels. This latter superfamily of channels 
contains two families that are going to be the topic of this review: the cyclic 
nucleotide-gated channel (CNG) channels and the hyperpolarization-activated, 
cyclic nucleotide-gated (HCN) channels. 
The study of ion channels involves many scientific techniques such as voltage clamp 
electrophysiology (in particular patch clamp), immunohistochemistry, and RT-PCR. 
 
2-  State of the art 
Cyclic adenosine 3',5’-monophosphate (cAMP) and cyclic guanosine 3',5’-
monophosphate (cGMP) are ubiquitous second messengers regulating a myriad of cellular 
functions. In the heart, the force of contraction (inotropy) and beating frequency (chronotropy) 
are under the dual control of the sympathetic and parasympathetic systems. Both systems 
control in an opposite manner the synthesis of cAMP, and, hence, the activity of the cAMP 
effectors (Fig. 1). Catecholamines released into the synaptic cleft at sympathetic nerve terminals 
bind to β1-adrenergic receptors (β1-ARs) on the cardiac sarcolemma, activate stimulatory G 
proteins (Gs), which in turn activate two isoforms of adenylyl cyclase (AC), AC5 and AC6, 
which catalyze the conversion of ATP to cAMP. cAMP exerts its effects then by activating the 
cAMP-dependent protein kinase (PKA), thereby promoting the phosphorylation and activation 
of key components of the excitation-contraction coupling (CEC) process. These include the 
sarcolemmal L-type Ca2+ channels (LTCC), responsible for the initial Ca2+ influx, the ryanodine 
receptors, that allow Ca2+ release from the sarcoplasmic reticulum (SR), troponin I, which 
controls myofilament sensitivity to Ca2+, and phospholamban, which regulates Ca2+ withdrawal 
from the cytosol and re-uptake into the SR (Bers, 2002). cAMP can also act in cardiac myocytes 
in a PKA-independent manner, through direct activation of Epac (Morel et al., 2005), a guanine 
nucleotide exchange factor for the small GTPase Rap1 (Bos, 2003), and HCN cyclic nucleotide-
gated ion channels (Baruscotti et al., 2005). As a mirror image, acetylcholine released into the 
synaptic cleft at parasympathetic nerve terminals binds to the muscarinic M2 receptors and 
induces AC inhibition via inhibitory G protein (Gi), thus decreasing PKA activation (Fig. 1) 
(Dhein et al., 2001).  
It is generally accepted that cGMP opposes the effect of cAMP on cardiac function 
(Fischmeister et al., 2005). Intracellular cGMP production is achieved by two different forms of 
guanylyl cyclases: a soluble form (sGC) which is activated by NO; a particulate form (pGC) 
which is activated by natriuretic peptides, such as ANP, BNP and CNP. cGMP mediates its 
effects by activating the cGMP-dependent protein kinase (PKG) thus reducing cardiac 
contractility by inhibition of LTCC activity and reduction of myofilament Ca2+ sensitivity (Méry 
et al., 1991; Layland et al., 2002; Schroder et al., 2003; Fischmeister et al., 2005). 
The intracellular level of these 2 second messengers is regulated by the balance between 
the activity of AC/GC and the cyclic nucleotide phosphodiesterases (PDEs) that degrade 
cAMP and cGMP to 5’AMP and 5’GMP, respectively. Cardiac PDEs fall into at least five 
families: PDE1, which is activated by Ca2+-calmodulin; PDE2, which is stimulated by cGMP; 
PDE3, which is inhibited by cGMP; PDE4 and PDE5. Whereas PDE1 and PDE2 can hydrolyze 
both cAMP and cGMP, PDE3 preferentially hydrolyzes cAMP; PDE4 and PDE 5 are specific for 
cAMP and cGMP, respectively. 
Although many studies have dissected cAMP and cGMP signaling pathways, there are a 
number of questions that have always made us wonder but have only lately begun to receive the 
attention they deserve: how so many different receptors coupled to cAMP or cGMP signaling 
pathway manage to achieve specific cellular responses? What is the purpose of the different 
adenylyl and guanylyl cyclases present in the same cell? Why do so many different cyclic 
nucleotide phosphodiesterases (PDEs) coexist to hydrolyze cAMP and cGMP? Do these cyclic 
nucleotides and their respective effectors freely diffuse inside the cell or are they localized? 
Some of these questions have received answers in recent studies combining molecular biology, 
fluorescence imaging, and electrophysiological approaches. In particular, compelling evidence is 
now accumulating about the formation of molecular complexes (signalosomes) in distinct 
cellular compartments that induce a localized cyclic nucleotide signaling in cardiomyocyte 
(Fischmeister et al., 2006).  
3- Methods to study cyclic nucleotide compartmentation in intact myocytes  
During twenty years, most of the evidence supporting a compartmentation of cyclic 
nucleotide signaling in cardiac preparations was gathered using biochemical assays in 
fractionated dead tissues or cells. However, these methods do not allow understanding the 
spatiotemporal organization of cyclic nucleotide signals in real time and in living cells. Hence, a 
number of sophisticated methods have been recently developed to monitor cyclic nucleotide 
changes using their own targets such as CNG channels (Rich et al., 2000), HCN channels 
(Nikolaev et al., 2006), PKA (Zaccolo et al., 2000), PKG (Honda et al., 2001), and Epac 
(Nikolaev et al., 2004) (Fig. 2).  
Some of these sensors, such as CNG channels, are based on their ionic channel 
properties: cAMP and or cGMP levels are measured either by fluorescent calcium probes or by 
patch clamp technique (Willoughby and Cooper, 2008); whereas, the remaining probes are based 
on the use of their cAMP and/or cGMP binding domain between YFP and CFP to track cyclic 
nucleotide-dependent changes by FRET (Fluorescence Resonance Energy transfer) between the 
two fluorescent proteins (fig. 3). Properties of these indicators are summarized in Table 1. 
 
Probe PKA Epac CNG channels HCN 
Methods FRET imaging FRET imaging Patch Clamp 
Calcium imaging 
FRET imaging 
Expression Microinjection 
Plasmid transfection; 
adenovirus infection 
Plasmid transfection; 
adenovirus infection 
adenovirus 
infection 
Transgenic mice 
overexpresssing 
HNC2-camps 
Dynamic 
 
≈ 0.02 µM - 5 µM 
≈ 1-100 µM 
 
≈ 5-100 µM (Epac : the 
whole protein) 
≈ 0.1-10 µM (Epac 
including cAMP 
binding domain) 
 
≈ 1-50µM 
(E583M) 
≈ 0.1-5 µM 
(C460W/E583M, 
∆61-
90/C460W/E583M) 
 
≈ 5 µM (in vitro) 
Excellent 
dynamic range 
Localization Cytosol, plasmic 
membrane, binding 
to AKAPs (PKA-
anchoring protein) 
Cytosol, plasmic 
membrane, 
mitochondria, 
nucleus 
plasmic 
membrane 
Homogenous 
distribution 
within the 
cytosol 
Temporal 
resolution 
Limited (many sec) Good (2 sec) Excellent (< 15 ms) Good 
 
Table 1: Properties of cAMP sensors. Adapted from (Willoughby & Cooper, 2008). 
 
 3.1- Cyclic nucleotide-gated channels: new indicators to track subsarcolemmal cAMP in 
single living cells 
 
A novel approach initially developed by the groups of Dermott Cooper and Jeff Karpen 
uses recombinant CNG channels as a probe to monitor cyclic nucleotide concentrations 
generated beneath the membrane (Rich et al., 2001). CNG channels were identified in 
photoreceptors and olfactory sensory neurons, where they translate changes in intracellular cyclic 
nucleotide concentration triggered by light or odorants into variations of the membrane potential. 
Native CNG channels consist of α- and β-subunits, with the α-subunit forming a non-specific 
cationic pore gated by cAMP or cGMP (Kaupp and Seifert, 2002). Upon binding of the cyclic 
nucleotide, CNG channels allow Na+, K+ and Ca2+ to enter the cell (Fig. 2) and this activity is 
easily detected using either patch-clamp or Ca2+-fluorescence measurements (Rich et al., 2000). 
CNG channels display several characteristics that make them valuable cyclic nucleotide sensors: 
their gating is fast; they do not desensitize; they are virtually voltage-insensitive; and they 
display an excellent dynamic range (Rich and Karpen, 2002). The rat olfactory α subunit 
(CNGA2) makes a valuable cGMP sensor that was used recently to show cGMP 
compartmentation in cardiac myocytes (Castro et al., 2006; Castro et al., 2010). In order to study 
selectively cAMP dynamics, Rich et al. (Rich et al., 2001) have made point mutations in 
CNGA2 to decrease the sensitivity to cGMP and increase the sensitivity to cAMP. In particular, 
the E583M mutation confers on the channel an EC50 for cAMP of approximately 10 μM, and the 
additional C460W mutation further increases the sensitivity, to approximately 1 μM. These 
CNGA2 mutants were incorporated into adenovirus constructs to allow efficient expression in 
various cell types (Vandecasteele et al., 2006). Adult cardiac myocytes infected with an 
adenovirus encoding the modified channels elicit a non-selective cation current that provides a 
reliable readout of subsarcolemmal cAMP fluctuations (Rochais et al., 2004; Rochais et al., 
2006; Leroy et al., 2008; Abi-Gerges et al., 2009).  
Because CNG channels are blocked by external and internal Ca2+ as well as by 
calmodulin (CaM), patch clamp experiments should be performed at nominal external [Ca2+] and 
internal pCa 8.5 (Rochais et al., 2004; Castro et al., 2006). Since Ca2+ regulates the activity of 
cardiac AC and PDEs, thus modulating cAMP signals, other CNG mutants ((∆61-
90/C460W/E583M or F68A/W81A/C460/E583M) that do not  bind to Ca2+/CaM complex have 
been generated later on (Rich et al., 2001; Willoughby and Cooper, 2007; Dubois, 1985).  
The use of CNG channels in HEK cells showed that the activation of prostaglandin E1 
(PGE1) receptors generates 2 types of cAMP signals: a rapid and transient increase of cAMP 
beneath the membrane while the increase in total cytosolic cAMP level is slow and sustained. 
The transient increase of submembrane cAMP was abolished after PDE inhibition (Rich et al., 
2001).  
In a series of studies performed in isolated rat cardiac myocytes, the use of CNG mutants 
showed the first evidence in real time that subsarcolemmal cAMP signals generated upon 
activation of different GPCRs are spatially confined in specific microdomains and are highly 
controlled by a specific pattern of PDEs (Rochais et al., 2004; Rochais et al., 2006). Besides, 
cAMP levels elicited upon a β-adrenergic stimulation were shown to be negatively tuned by 
PKA-mediated activation of PDE3/PDE4 (Rochais et al., 2004). Leroy and colleagues combined 
the use of the CNG channels with the FRET-based sensor, Epac2-camps in order to monitor 
respectively cAMP signals generated beneath the membrane and in the cytosol (Leroy et al., 
2008).  
Biochemical assays showed that the cAMP pathway is altered during cardiac 
hypertrophy and heart failure. Using the engineered CNG channels, we provided the first 
evidence, in real time and on living, hypertrophied cardiac myocytes, that subsarcolemmal 
cAMP signals generated upon the activation of β-adrenergic receptors are blunted compared to 
normal cardiac myocytes. The regulation of these cAMP domains by PDEs is also altered during 
hypertrophy (Abi-Gerges et al., 2009). 
 
3.2- Hyperpolarization-activated, cyclic nucleotide-gated channels: a novel sensor to 
monitor cytosolic cAMP in living cells 
 
Hyperpolarization-activated, cyclic nucleotide-gated cation channels (HCN) are voltage-
dependent channels activated by hyperpolarization and sensitive to the cyclic nucleotides, cAMP 
and cGMP. They are permeable to the monovalent cations K+ and Na+. In vertebrate, HCN 
family comprises 4 members (HCN1-4). While HCN3 is specifically expressed in neurons, the 3 
other channels (HCN 1, 2 and 4) are detected in heart and brain. The HCN4 isoform is mainly 
expressed in sino-atrial cells while HCN2 is dominant in atrial and ventricular myocytes. HCN 
channels have, in their C-terminal part, a cyclic-nucleotide binding domain which is similar to 
the one that is present in PKA, PKG, Epac and CNG channels. The current associated to these 
channels is known as the ‘funny’ current (If) or the pacemaker current. It contributes to the 
generation of the cardiac automatism in the cells of the sino-atrial and atrio-ventricular node 
(Biel et al., 2002; Mangoni and Nargeot, 2008). 
cAMP probes based on the use of PKA and Epac have the inherent disadvantage that 
their sensitivity is relatively high (affinity for cAMP ≈1 μM). Therefore, the determination of 
cAMP with these constructs is limited to the low range of cAMP concentrations, which is 
inadapted to cells in which cAMP can reach micromolar concentrations, such as cardiac 
myocytes. Therefore, Nikolaev and colleagues have developed a novel sensor with optimized 
sensitivity to cAMP based on the use of a single cytoplasmic cAMP binding domain of HCN2 
channel endogenously expressed in the heart, known as HCN2-camps (Nikolaev et al., 2006). 
Based on the crystal structure of HCN2, they fused its cAMP binding domain between YFP and 
CFP to monitor cAMP-dependent conformational changes by FRET between the 2 fluorescent 
proteins (Fig. 3). This sensor, isolated from HEK293 cells, demonstrated micromolar affinities 
for cAMP whereas cGMP activated the sensor only partially at high micromolar concentrations. 
HCN2-camps sensor was expressed in a cardiomyocyte-specific manner in the hearts of 
transgenic mice in order to study spatial and temporal cAMP dynamics after β1- and β2-
adrenergic subtype stimulation in freshly isolated adult cardiac myocytes. Using this probe that is 
uniformly expressed in the cell, the authors showed that a localized β1-adrenergic stimulation 
generated a cAMP gradient propagating throughout the cell, whereas local β2-adrenergic 
stimulation elicited confined cAMP pools. Besides, the activation of β1-adrenergic receptors 
elicited cAMP signals that were entirely controlled by PDE4, whereas the activation of β2-
adrenergic receptors generated cAMP signals regulated by multiple PDE isoforms. Even after 
PDE inhibition, the β2-adrenergic-mediated cAMP signals were still confined within the cells 
suggesting a role of the cell architecture in cAMP compartmentation (Nikolaev et al., 2006). 
 
 
4- Conclusion 
A number of different probes are now available for real time measurements of 
cAMP(Nikolaev et al., 2004; Zaccolo, 2004; Nikolaev et al., 2005) and cGMP in living cells, 
including cardiac myocytes. The first approach is based on the properties of CNG channels that 
are directly activated by the increase of cAMP and cGMP concentrations beneath the membrane. 
In order, to visualize changes in cyclic nucleotide levels within the cytosol, another type of 
approach based on FRET imaging has been developed using cAMP and cGMP targets. 
Combining the two techniques allows a better understanding of the spatiotemporal organization 
of cyclic nucleotide signaling in many cell types.  
Summary 
Signaling cascades involving cyclic nucleotides play key roles in signal transduction in virtually 
all cell types. A current challenge in research today is to decipher the spatiotemporal regulation 
of cyclic nucleotide signaling that any given cell type has concocted to be able to discriminate 
among different external stimuli acting via a common signaling pathway. New approaches based 
on the use of ion channels as biosensors have been recently developed in order to track the 
dynamics of cAMP and cGMP as well as the activities of their regulators and effectors in the 
native biological context. This obviously applies to cyclic nucleotide gated channels (CNG) 
(Fagan et al., 2001; Rich et al., 2001; Rich et al., 2001; Brady et al., 2004) and the 
hyperpolarization-activated cyclic nucleotide-gated channels (HCN) (Nikolaev et al., 2006) 
whose high sensitivity to cAMP and/or cGMP allow to monitor in real time and in living cells 
the signals encoded by these second messengers (Rochais et al., 2004; Rochais et al., 2006; 
Castro et al., 2006; Leroy et al., 2008; Castro et al., 2010; Abi-Gerges et al., 2009). Here we 
review a series of genetically encoded probes based on the use of CNG and HCN channels for 
real-time monitoring of cyclic nucleotide signaling with a particular focus on their 
implementation in cardiac myocytes.  
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Figure Legends 
Figure 1: Regulation of cardiac excitation-contraction coupling by cAMP pathways 
Upon liberation of noradrenaline by sympathetic nerve terminals, β1-ARs activate cardiac AC 
isoforms (AC5 and AC6) via the stimulatory G protein (Gs). Cyclic AMP is being synthesized 
and activates PKA which phosphorylates different intracellular targets: LTCC phosphorylation 
leads to an increased Ca2+ influx and RyR2 phosphorylation at the SR membrane to an 
increased Ca2+-induced Ca2+ release, both acting to enhance the force of contraction; PLB 
phosphorylation leads to an increased SR Ca2+ uptake by SERCA and TnI phosphorylation to a 
reduction in Ca2+-sensitivity of the myofilaments, both acting to accelerate contractile 
relaxation; on the long term, CREB phosphorylation in the nucleus activates transcription. These 
effects are antagonized by a liberation of acetylcholine from parasympathetic nerve terminals, 
through activation of muscarinic M2 receptors and inhibition of AC activity via inhibitory G 
proteins (Gi).  
 
Figure 2: CNG channels as cyclic nucleotide biosensors 
(A) Expression of CNGA2 as revealed by confocal microscopy in native and Ad-CNG 
(adenovirus carrying CNG)-infected adult rat ventricular myocytes cultured for 24 h. CNGA2 
mutant was detected using a mouse monoclonal anti-CNGA2 kindly provided by Dr F. Muller 
and Professor U.B. Kaupp (Institute for Biological Information Processing, Research Centre 
Julich, Julich, Germany). No CNG channels were detected in non-infected (NI) cells, whereas 
Ad-CNG-infected cells demonstrated a rather ubiquitous pattern of expression with accentuation 
of the staining at the Z-lines. (B) Recombinant CNG channels. Wild-type or genetically modified 
 subunits of rat olfactory CNG channel (CNGA2) form a cationic channel directly opened by 
cyclic nucleotides (CN). (C) Cardiomyocytes infected with an adenovirus encoding the native or 
modified channels elicit a non-selective cation current (ICNG) only when CN concentration rises 
beneath the sarcolemmal membrane. 
 
Figure 3: HCN channels as cAMP biosensors 
(A) FRET-based imaging method. YFP and CFP proteins are fused to a cyclic nucleotide (CN) 
binding protein (for instance, HCN, Epac or a catalytic-inactive PKG). CN binding reduces 
FRET between CFP and YFP and the change in shape of the fluorescence emission spectrum 
allows CN concentrations to be visualized in real-time. (B) CN imaging in a living cell (rat 
ventricular myocyte). CFP/YFP ratio is expressed in color code and is proportional to CN 
concentration within the cell. 
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